Parnax Lab Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 11.49 Cr
as on 12-12-2024
- Company Age 42 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 24.20 Cr
as on 12-12-2024
- Satisfied Charges ₹ 4.66 Cr
as on 12-12-2024
- Revenue 199.91%
(FY 2022)
- Profit 147.82%
(FY 2022)
- Ebitda 407.59%
(FY 2022)
- Net Worth 170.46%
(FY 2022)
- Total Assets 33.41%
(FY 2022)
About Parnax Lab
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506128.
The Corporate was formerly known as Krishna-Deep Trade And Investment Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 11.49 Cr.
The company currently has active open charges totaling ₹24.20 Cr. The company has closed loans amounting to ₹4.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Parnax Lab Limited India are Preet Kukreja as Company Secretary, Binoy Shah as Cfo, and Mihir Shah as Ceo. Mihir Shah, Binoy Shah, Ami Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
L36912MH1982PLC027925
- Company No.
027925
- Stock Symbol
BSE : 506128
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1982
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Parnax Lab?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mihir Shah  | Managing Director | 05-Jul-2024 | Current |
| Preet Kukreja | Company Secretary | 21-Jun-2021 | Current |
| Binoy Shah | CFO | 03-Aug-2024 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Binoy Shah | Director | 05-Jul-2024 | Current |
| Ami Shah | Director | 31-Mar-2015 | Current |
| Tirunillai Anatharaman | Director | 31-Mar-2015 | Current |
| Yogesh Varia | Director | 28-May-2021 | Current |
| Harish Panpalia | Director | 11-Aug-2023 | Current |
Financial Performance of Parnax Lab.
Parnax Lab Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 199.91% increase. The company also saw a substantial improvement in profitability, with a 147.82% increase in profit. The company's net worth Soared by an impressive increase of 170.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parnax Lab?
In 2022, Parnax Lab had a promoter holding of 67.58% and a public holding of 32.42%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Naxpar Health Concepts Private LimitedActive 20 years 6 monthsBinoy Shah and Ami Shah are mutual person
Naxpar Pharma Private LimitedActive 20 years 10 monthsMihir Shah, Yogesh Varia and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Sep 2002 | ₹10.39 Cr | Open |
State Bank Of India Creation Date: 30 Mar 2000 | ₹2.72 Cr | Open |
State Bank Of India Creation Date: 30 Mar 2000 | ₹10.39 Cr | Open |
How Many Employees Work at Parnax Lab?
Unlock and access historical data on people associated with Parnax Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parnax Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parnax Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
